Toxicity of high-dose methotrexate administration at the Sidney Kimmel Cancer Center (SKCC): A retrospective review to guide establishment of an outpatient treatment program.

Kelsey Sokol,Kelley Yuan,Katlin Fendler,Samantha Burdette,Patricia Galanis,Maria Piddoubny,Anne Delengowski,Carol Gung,Mercy George,Onder Alpdogan,Ubaldo Martinez-Outschoorn,Pierluigi Porcu,Adam Binder

Toxicity of high-dose methotrexate administration at the Sidney Kimmel Cancer Center (SKCC): A retrospective review to guide establishment of an outpatient treatment program.

2020

Kelsey Sokol
Kelley Yuan
Katlin Fendler
Samantha Burdette
Patricia Galanis
Maria Piddoubny
Anne Delengowski
Carol Gung
Mercy George
Onder Alpdogan
Ubaldo Martinez-Outschoorn
Pierluigi Porcu
Adam Binder

30Background: High-dose methotrexate (HDMTX) is administered for the treatment of primary central nervous system (CNS) lymphoma (PCNSL), leptomeningeal metastases, and osteosarcoma, as well as CNS ...

Keywords:

Oncology
Methotrexate
Internal medicine
high dose methotrexate
retrospective review
Toxicity
Cancer
Lymphoma
Osteosarcoma
Medicine
Central nervous system

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations